Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
873.68
+0.56 (0.06%)
At close: Feb 21, 2025, 4:00 PM
872.29
-1.39 (-0.16%)
After-hours: Feb 21, 2025, 7:55 PM EST
Eli Lilly Operating Expense Breakdown
History
| Date | Research and Development | Marketing, Selling, and Administrative | Impairment, Restructuring, and Other | Acquired In-Process Research and Development |
|---|---|---|---|---|
| Dec 31, 2024 | 10.99B | 8.59B | 860.60M | 3.28B |
| Sep 30, 2024 | 10.53B | 8.09B | 523.37M | 3.71B |
| Jun 30, 2024 | 10.21B | 7.80B | 441.77M | 3.86B |
| Mar 31, 2024 | 9.85B | 7.61B | - | 3.81B |
| Dec 31, 2023 | 9.31B | 7.40B | 6.77M | 3.80B |
| Sep 30, 2023 | 8.75B | 7.12B | - | 3.42B |
| Jun 30, 2023 | 8.14B | 6.93B | - | 504.60M |
| Mar 31, 2023 | 7.57B | 6.63B | - | 847.90M |
| Dec 31, 2022 | 7.19B | 6.44B | 244.60M | 908.50M |
| Sep 30, 2022 | 7.15B | 6.39B | 311.00M | 1.11B |
| Jun 30, 2022 | 7.06B | 6.35B | - | 1.22B |
| Mar 31, 2022 | 6.95B | 6.41B | - | 823.70M |
| Dec 31, 2021 | 7.03B | 6.43B | 316.10M | 970.10M |
| Sep 30, 2021 | 6.90B | 6.39B | - | 898.70M |
| Jun 30, 2021 | 6.66B | 6.38B | - | 721.10M |
| Mar 31, 2021 | 6.38B | 6.15B | 282.90M | 920.10M |
| Dec 31, 2020 | 6.09B | 6.12B | 131.20M | 660.40M |
| Sep 30, 2020 | 5.83B | 6.27B | 313.00M | - |
| Jun 30, 2020 | 5.74B | 6.11B | - | 371.80M |
| Mar 31, 2020 | 5.76B | 6.25B | 211.60M | 155.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.